2014 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 2
TABLE 2. Estimated percent of active1 and inactive2 asthma status among adults3 ever diagnosed with asthma by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2014
| State/Territory | Sample size± |
Active | Inactive | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | ||
| Connecticut | 298 | 228 | 73.3 | 3.9 | (65.7 – 80.9) | 70 | 26.7 | 3.9 | (19.1 – 34.3) |
| District of Columbia | 156 | 112 | 62.4 | 8.5 | (45.7 – 79.1) | 44 | 37.6 | 8.5 | (20.9 – 54.3) |
| Georgia | 186 | 139 | 59.6 | 7.0 | (45.9 – 73.3) | 47 | 40.4 | 7.0 | (26.7 – 54.1) |
| Hawaii | 292 | 196 | 64.1 | 4.4 | (55.5 – 72.7) | 96 | 35.9 | 4.4 | (27.3 – 44.5) |
| Illinois | 285 | 202 | 63.1 | 4.5 | (54.3 – 71.9) | 83 | 36.9 | 4.5 | (28.1 – 45.7) |
| Indiana | 616 | 512 | 81.4 | 2.4 | (76.7 – 86.1) | 104 | 18.6 | 2.4 | (13.9 – 23.3) |
| Iowa | 344 | 253 | 62.2 | 4.0 | (54.4 – 70.0) | 91 | 37.8 | 4.0 | (30.0 – 45.6) |
| Maine | 371 | 312 | 82.1 | 2.9 | (76.4 – 87.8) | 59 | 17.9 | 2.9 | (12.2 – 23.6) |
| Maryland | 295 | 221 | 70.4 | 4.9 | (60.8 – 80.0) | 74 | 29.6 | 4.9 | (20.0 – 39.2) |
| Michigan | 543 | 450 | 81.2 | 2.5 | (76.3 – 86.1) | 93 | 18.8 | 2.5 | (13.9 – 23.7) |
| Mississippi | 181 | 137 | 70.6 | 6.4 | (58.1 – 83.1) | 44 | 29.4 | 6.4 | (16.9 – 41.9) |
| Missouri | 311 | 260 | 79.3 | 3.5 | (72.4 – 86.2) | 51 | 20.7 | 3.5 | (13.8 – 27.6) |
| Montana | 338 | 265 | 74.0 | 4.3 | (65.6 – 82.4) | 73 | 26.0 | 4.3 | (17.6 – 34.4) |
| Nebraska | 949 | 727 | 71.0 | 2.7 | (65.7 – 76.3) | 222 | 29.0 | 2.7 | (23.7 – 34.3) |
| Nevada | 190 | 151 | 78.4 | 4.7 | (69.2 – 87.6) | 39 | 21.6 | 4.7 | (12.4 – 30.8) |
| New Hampshire | 276 | 231 | 85.8 | 3.2 | (79.5 – 92.1) | 45 | 14.2 | 3.2 | (7.9 – 20.5) |
| New Jersey | 564 | 452 | 76.1 | 3.0 | (70.2 – 82.0) | 112 | 23.9 | 3.0 | (18.0 – 29.8) |
| New Mexico | 342 | 258 | 72.1 | 3.8 | (64.7 – 79.5) | 84 | 27.9 | 3.8 | (20.5 – 35.3) |
| New York | 151 | 120 | 77.1 | 4.8 | (67.7 – 86.5) | 31 | 22.9 | 4.8 | (13.5 – 32.3) |
| North Carolina | 154 | 137 | 79.3 | 6.9 | (65.8 – 92.8) | 17 | N/A | N/A | (N/A – N/A) |
| Ohio | 445 | 362 | 75.3 | 3.5 | (68.4 – 82.2) | 83 | 24.7 | 3.5 | (17.8 – 31.6) |
| Oklahoma | 313 | 221 | 61.9 | 3.8 | (54.5 – 69.3) | 92 | 38.1 | 3.8 | (30.7 – 45.5) |
| Oregon | 278 | 194 | 68.2 | 4.8 | (58.8 – 77.6) | 84 | 31.8 | 4.8 | (22.4 – 41.2) |
| Pennsylvania | 539 | 432 | 75.5 | 3.0 | (69.6 – 81.4) | 107 | 24.5 | 3.0 | (18.6 – 30.4) |
| Rhode Island | 244 | 212 | 82.3 | 5.0 | (72.5 – 92.1) | 32 | 17.7 | 5.0 | (7.9 – 27.5) |
| Texas | 703 | 531 | 66.2 | 3.7 | (58.9 – 73.5) | 172 | 33.8 | 3.7 | (26.5 – 41.1) |
| Utah | 738 | 547 | 70.4 | 2.3 | (65.9 – 74.9) | 191 | 29.6 | 2.3 | (25.1 – 34.1) |
| Vermont | 323 | 254 | 75.4 | 3.1 | (69.3 – 81.5) | 69 | 24.6 | 3.1 | (18.5 – 30.7) |
| Washington | 512 | 391 | 72.3 | 3.9 | (64.7 – 79.9) | 121 | 27.7 | 3.9 | (20.1 – 35.3) |
| West Virginia | 286 | 240 | 79.0 | 3.5 | (72.1 – 85.9) | 46 | 21.0 | 3.5 | (14.1 – 27.9) |
| Wisconsin | 304 | 254 | 80.1 | 4.1 | (72.1 – 88.1) | 50 | 19.9 | 4.1 | (11.9 – 27.9) |
| Puerto Rico | 549 | 390 | 67.3 | 2.9 | (61.6 – 73.0) | 159 | 32.7 | 2.9 | (27.0 – 38.4) |
| 32 state total | 12,076 | 9,391 | 72.7 | 1.0 | (70.7 – 74.7) | 2,685 | 27.3 | 1.0 | (25.3 – 29.3) |
| Median | 73.7 | 26.7 | |||||||
| Range | 59.6-85.8 | 14.2-40.4 | |||||||
1 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
2 Reported none of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 Aged ≥ 18 years
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30
Page last reviewed: February 13, 2017